These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 220988)

  • 21. Lactic acid levels in cerebrospinal fluid from patients with systemic lupus erythematosus.
    Brook I; Controni G; Kassan SS; Moutsopoulos HM
    J Rheumatol; 1979; 6(6):691-3. PubMed ID: 529253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren's syndrome or systemic lupus erythematosus.
    Sanders ME; Alexander EL; Koski CL; Frank MM; Joiner KA
    J Immunol; 1987 Apr; 138(7):2095-9. PubMed ID: 3559203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid interleukin-6, prostaglandin E2 and autoantibodies in patients with neuropsychiatric systemic lupus erythematosus and central nervous system infections.
    Tsai CY; Wu TH; Tsai ST; Chen KH; Thajeb P; Lin WM; Yu HS; Yu CL
    Scand J Rheumatol; 1994; 23(2):57-63. PubMed ID: 8165438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropsychiatric lupus.
    Abel T; Gladman DD; Urowitz MB
    J Rheumatol; 1980; 7(3):325-33. PubMed ID: 6249928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus.
    Isshi K; Hirohata S
    Arthritis Rheum; 1998 Oct; 41(10):1819-27. PubMed ID: 9778223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of interferon-α as a biomarker in central neuropsychiatric involvement in systemic lupus erythematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Núñez-Alvarez CA; Llorente L; Sánchez-Guerrero J
    J Rheumatol; 2012 Mar; 39(3):504-9. PubMed ID: 22247358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cerebrospinal fluid complement and antinuclear antibodies in lupus meningoencephalitis].
    Hazouard E; Legras A; Diot E; Ferrandière M; Corcia P; Giniès G
    Rev Neurol (Paris); 1998 Jul; 154(6-7):549-50. PubMed ID: 9773091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus.
    Trysberg E; Höglund K; Svenungsson E; Blennow K; Tarkowski A
    Arthritis Res Ther; 2004; 6(2):R129-36. PubMed ID: 15059276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased intrathecal immunoglobulin synthesis of both kappa and lambda types in patients with systemic lupus erythematosus and central nervous system involvement.
    Hirohata S; Miyamoto T
    J Rheumatol; 1986 Aug; 13(4):715-21. PubMed ID: 3095548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
    Amezcua-Guerra LM; Springall R; Arrieta-Alvarado AA; Rodríguez V; Rivera-Martinez E; Castillo-Martinez D; Bojalil R
    Clin Lab; 2011; 57(7-8):607-13. PubMed ID: 21888025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of systemic lupus erythematosus with various central and peripheral neurological disorders presenting with motor paralytic bladder as a major manifestation].
    Horiki T; Moriuchi J; Kouzuma R; Haida M; Watanabe S; Katsuoka Y; Ichikawa Y
    Ryumachi; 1995 Oct; 35(5):821-6. PubMed ID: 8594661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement.
    Trysberg E; Carlsten H; Tarkowski A
    Lupus; 2000; 9(7):498-503. PubMed ID: 11035414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for intrathecal synthesis of autoantibodies in systemic lupus erythematosus with neurological involvement.
    Mevorach D; Raz E; Steiner I
    Lupus; 1994 Apr; 3(2):117-21. PubMed ID: 7920611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction.
    Winfield JB; Shaw M; Silverman LM; Eisenberg RA; Wilson HA; Koffler D
    Am J Med; 1983 May; 74(5):837-44. PubMed ID: 6837607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiganglioside antibodies in cerebrospinal fluid of children with neuropsychiatric lupus erythematosus.
    Chen Y; Wu F; Hou L; Ma S; He X
    Chin Med J (Engl); 1997 Aug; 110(8):594-7. PubMed ID: 9594260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies.
    Fields RA; Sibbitt WL; Toubbeh H; Bankhurst AD
    Ann Rheum Dis; 1990 Feb; 49(2):114-7. PubMed ID: 2317112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concentration of soluble adhesion molecules (sVCAM-1, sICAM-1 and sL-selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement.
    Baraczka K; Nékám K; Pozsonyi T; Jakab L; Szongoth M; Seszták M
    Neuroimmunomodulation; 2001; 9(1):49-54. PubMed ID: 11435752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble interleukin 2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in patients with systemic lupus erythematosus.
    Raziuddin S; al-Janadi MA; al-Wabel AA
    J Rheumatol; 1991 Jun; 18(6):831-6. PubMed ID: 1680190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent observations on central nervous system lupus erythematosus.
    Bennahum DA; Messner RP
    Semin Arthritis Rheum; 1975 Feb; 4(3):253-66. PubMed ID: 1091976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychiatric manifestations of systemic lupus erythematosus: clinical features, symptoms, and signs of central nervous system activity in 43 patients.
    Miguel EC; Pereira RM; Pereira CA; Baer L; Gomes RE; de Sá LC; Hirsch R; de Barros NG; de Navarro JM; Gentil V
    Medicine (Baltimore); 1994 Jul; 73(4):224-32. PubMed ID: 8041245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.